Targeted tumor coating with antigenic, CTL-recognizable peptides via Annexin A5 chimeric constructs following chemotherapy redirects adaptive CD8+ T cell immunity for tumor clearance

Documenti analoghi

• Targeted Coating With Antigenic Peptide Renders Tumor Cells Susceptible to CD8(+) T Cell-mediated Killing
  di: Kang, Tae Heung, et al.
  Pubblicazione: (2013)
• Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor
  di: Jena, Bipulendu, et al.
  Pubblicazione: (2010)
• Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment
  di: Kang, Tae Heung, et al.
  Pubblicazione: (2020)
• Chimeric Antigen Receptor-Redirected T cells return to the bench
  di: Geldres, Claudia, et al.
  Pubblicazione: (2016)
• Conditional Superagonist CTL Ligands for the Promotion of Tumor-Specific CTL responses
  di: Abdul-Alim, C. Siddiq, et al.
  Pubblicazione: (2010)